News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Santillana Sergio L.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/05/2023 |
4
| Santillana Sergio L. (Chief Medical Officer) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 105,000 options to buy
@ $2.62, valued at
$275.1k
|
|
| 02/04/2022 |
4
| Santillana Sergio L. (Chief Medical Officer) has filed a Form 4 on Ikena Oncology, Inc.|
Txns:
| Granted 70,400 options to buy
@ $11.45, valued at
$806.1k
|
|
| 03/30/2021 |
3/A
| Santillana Sergio L. (Chief Medical Officer) has filed a Form 3/A on Ikena Oncology, Inc. |
| 03/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/13/2018 |
4
| Santillana Sergio L. (Chief Medical Officer) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC|
Txns:
| Granted 45,000 options to buy
@ $4.15, valued at
$186.8k
|
|
| 02/16/2018 |
4
| Santillana Sergio L. (Chief Medical Officer) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC|
Txns:
| Granted 45,000 options to buy
@ $10.74, valued at
$483.3k
|
|
| 06/15/2017 |
3
| Santillana Sergio L. (Chief Medical Officer) has filed a Form 3 on MERRIMACK PHARMACEUTICALS INC |
|
|